August 2026 in “Acta Dermato Venereologica” CCCA patients often have high rates of dyslipidemia, uterine leiomyomas, and anxiety disorders.
July 2026 in “The Professional Medical Journal” Long COVID often causes hair loss, headaches, fatigue, concentration issues, muscle pain, taste loss, dry mouth, mouth sores, and gum problems.
July 2026 in “Journal of Investigative Dermatology” Alopecia totalis/universalis is linked to more autoimmune diseases than patchy alopecia areata.
July 2026 in “Annals of Medicine and Surgery” Age and sex affect lupus symptoms over time, requiring tailored monitoring.
June 2026 in “Mediterranean Journal of Hematology and Infectious Diseases” The girl's lupus with kidney and immune complications didn't improve with strong treatment.
June 2026 in “Pediatric Drugs” Current treatments for severe alopecia areata in children are often ineffective, with frequent relapses and long treatment durations.
June 2026 in “Scientific Reports” Testosterone makes XX skin more like male skin by changing its structure and cell makeup.
COVID-19 vaccines are generally safe for people with lupus, though some may experience mild flare symptoms.
Combining platelet-rich plasma with other treatments may improve hair growth in androgenetic alopecia.
Combining platelet-rich plasma with other treatments may improve hair growth in androgenetic alopecia.
May 2026 in “Skin Appendage Disorders” Combining PRP with other treatments may improve hair growth more than PRP alone.
May 2026 in “Mayo Clinic Proceedings” Early diagnosis and coordinated care are crucial for managing lupus effectively.
April 2026 in “Clinical and Experimental Dermatology” Alopecia areata causes significant emotional distress, requiring treatments that focus on mental health and social support, not just hair regrowth.
April 2026 in “Mendeley Data” Topical hair loss treatments have a stronger placebo effect than systemic ones.
April 2026 in “Mendeley Data” Topical treatments for hair loss have a stronger placebo effect than systemic ones.
April 2026 in “The National Medical Journal of India” Regular eye exams are important for detecting serious complications in lupus patients.
April 2026 in “SHILAP Revista de lepidopterología” Early diagnosis and treatment of myositis in SLE patients lead to better outcomes.
March 2026 in “Lithuanian University of Health Sciences” Finasteride, dutasteride, and oral minoxidil are effective for treating hair loss, with spironolactone as an option for women.
Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.
March 2026 in “Clinical and Experimental Dermatology” Facial hair loss and psychosocial issues are crucial in deciding treatment for alopecia areata.
Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.
January 2026 in “Journal of Clinical Medicine” Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.
Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.
January 2026 in “Saudi Journal of Internal Medicine” Depression and anxiety are common in SLE patients and worsen disease symptoms.
December 2025 in “Chinese Medical Journal” Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.
December 2025 in “Cosmoderma” Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.
December 2025 in “Cureus” SLE can occur in young males and cause knee pain.
December 2025 in “JEADV Clinical Practice” These new skin treatments are safer and more effective with minimal side effects.
December 2025 in “Philippine Journal of Internal Medicine” Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.
December 2025 in “Fertility and Sterility” Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.